| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 9.6 | 8.9 | 8.6 |
| Other income | 1.5 | 1.6 | 1.6 |
| Total income | 11.0 | 10.5 | 10.2 |
| Profit before exceptional items & tax | -0.6 | -1.0 | 1.3 |
| Exceptional items | 0.0 | 0.1 | 0.0 |
| Profit before tax | -0.6 | -0.9 | 1.3 |
| Net profit | -0.5 | -3.2 | 1.0 |
| Operating margin | -5.5% | -8.6% | 12.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +11.60% |
|---|---|
| Operating profit, year on year | -233.30% |
| Operating profit, quarter on quarter | +58.30% |
Source
Read the filing ↗
BSE results filing, NSE: ZENOTECH. Figures extracted from the filing.
Zenotech Laboratories Ltd: key numbers
- Share price
- ₹42.15
- Market cap
- ₹257.2 Cr
- Revenue (annual)
- ₹43.61 Cr
- Net profit (annual)
- ₹-1.07 Cr
- P/E (TTM)
- -102.2×Sector 50.4×
- Promoter holding
- 68.84%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenotech Laboratories Ltd
All →
15:25 IST
BSE
Annual General Meeting
Zenotech Laboratories Annual General Meeting
Zenotech Laboratories Limited concluded its 37th Annual General Meeting. Shareholders approved the adoption of financial statements and re-appointment of Mr. Jignesh Anantray Goradia as Director.
16:12 IST
BSE
Financial Results
Zenotech Laboratories Q4 FY26 Results: Net Loss of ₹3.2 Cr
Zenotech Laboratories Ltd reported revenue from operations of ₹8.9 Cr (-19.8% YoY) and a net loss of ₹3.2 Cr for Q4 FY26.
- Key figure
- Net loss ₹3.2 Cr